-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a study published in the journal Gastroenterology showed for the first time that bariatric surgery may significantly reduce the risk of cancer in patients with severe obesity and non-alcoholic fatty liver (NAFLD), especially those related to obesity The risk of cancer, the risk may be reduced by half.
Bariatric surgery may significantly reduce the risk of cancer in patients with severe obesity and non-alcoholic fatty liver (NAFLD).
Vinod K.
Vinod K.
In the database of the institute, 2,043,936 participants were diagnosed with NAFLD.
Population baseline characteristics
Population baseline characteristicsThere were 1 898 cancer incidents in 115 890.
In the risk model, the number of obesity-related cancer events in NAFLD patients with and without surgery was 258 and 653, respectively.
The cumulative incidence of any cancer and obesity-related cancers in patients undergoing bariatric surgery is lower than in patients who have not undergone surgery.
The risk of all types of cancer was reduced by 18%, and the risk of obesity-related cancer was reduced by 25%.
Bariatric surgery may be associated with a significantly reduced risk of obesity-related cancers: colorectal cancer, pancreatic cancer, endometrial cancer, thyroid cancer, hepatocellular carcinoma, and multiple myeloma.
Dr.
In addition, researchers are studying the effects of bariatric surgery on cardiovascular disease, such as whether it will reduce heart attacks or strokes.
Leave a message here